Biblio Discovery — Demo Discovery Service

9 hasil untuk "Aleksei A. Stepanenko"

Menampilkan 1–9 · 0,66 detik · RSS

  1. Artikel Jurnal

    A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation

    Aleksei A. Stepanenko; Anastasiia O. Sosnovtseva; Marat P. Valikhov dkk.

    Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Two-cycle cesium chloride (2 × CsCl) gradient ultracentrifugation is a conventional approach for purifying recombinant adenoviruses (rAds) for research purposes (gene therapy, vaccines, and oncolytic vectors). However, rAds containing the RGD-4C peptide in the HI loop of the fiber knob…

  2. Artikel Jurnal

    Systemic and local immunosuppression in glioblastoma and its prognostic significance

    Aleksei A. Stepanenko; Anastasiia O. Sosnovtseva; Marat P. Valikhov dkk.

    Frontiers in Immunology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

    The effectiveness of tumor therapy, especially immunotherapy and oncolytic virotherapy, critically depends on the activity of the host immune cells. However, various local and systemic mechanisms of immunosuppression operate in cancer patients. Tumor-associated immunosuppression involves…

  3. Artikel Jurnal

    The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy

    Aleksei A. Stepanenko; Anastasiia O. Sosnovtseva; Marat P. Valikhov dkk.

    Frontiers in Immunology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

    Despite significant advances in our knowledge regarding the genetics and molecular biology of gliomas over the past two decades and hundreds of clinical trials, no effective therapeutic approach has been identified for adult patients with newly diagnosed glioblastoma, and overall survival remains…

  4. Artikel Jurnal

    Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?

    Victor A. Naumenko; Aleksei A. Stepanenko; Anastasiia V. Lipatova dkk.

    Molecular Therapy: Oncolytics, Vol. 24 · 2022 · Inggris · DOAJ

    Oncolytic viruses are designed to specifically target cancer cells, sparing normal cells. Although numerous studies demonstrate the ability of oncolytic viruses to infect a wide range of non-tumor cells, the significance of this phenomenon for cancer virotherapy is poorly understood. To fill the…

  5. Artikel Jurnal

    Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury

    Anastasiia O. Sosnovtseva; Olga V. Stepanova; Aleksei A. Stepanenko dkk.

    Frontiers in Pharmacology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    The regeneration of nerve tissue after spinal cord injury is a complex and poorly understood process. Medication and surgery are not very effective treatments for patients with spinal cord injuries. Gene therapy is a popular approach for the treatment of such patients. The delivery of therapeutic…

  6. Artikel Jurnal

    Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD

    Aleksei A. Stepanenko; Anastasiia O. Sosnovtseva; Anastasiia A. Vasiukova dkk.

    Molecular Therapy: Oncology, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    The oncolytic adenovirus Ad5-delta-24-RGD (Ad5Δ24RGD) exhibits suboptimal therapeutic efficacy in high-grade glioma. Here, we show that combining two specific potency-enhancing mutations in E3-19K and i-leader (designated 19KSS-iLQ125Ter) markedly increases the cytolytic efficiency and the size of…

  7. Artikel Jurnal

    Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures

    Aleksei A. Stepanenko; Anastasiia O. Sosnovtseva; Marat P. Valikhov dkk.

    Molecular Therapy: Oncolytics, Vol. 24 · 2022 · Inggris · DOAJ

    Ad5-delta-24-RGD is currently the most clinically advanced recombinant adenovirus (rAd) for glioma therapy. We constructed a panel of fiber-modified rAds (Ad5RGD, Ad5/3, Ad5/35, Ad5/3RGD, and Ad5/35RGD, all harboring the delta-24 modification) and compared their infectivity, replication…

  8. Artikel Jurnal Teks lengkap

    In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells

    Victor A. Naumenko; Daniil A. Vishnevskiy; Aleksei A. Stepanenko dkk.

    Biomedicines, Vol. 10 No. 7 · 2022 · Inggris · DOAJ Scopus

    Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity…